Pharmacokinetics of the Dietary Supplement Creatine View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2003-05

AUTHORS

Adam M. Persky, Gayle A. Brazeau, Günther Hochhaus

ABSTRACT

Creatine is a nonessential dietary component that, when supplemented in the diet, has shown physiological benefits in athletes, in animal-based models of disease and in patients with various muscle, neurological and neuromuscular disease. The clinical relevance of creatine supplementation is based primarily on its role in ATP generation, and cells may be able to better handle rapidly changing energy demands with supplementation.Although the pharmacological outcome measures of creatine have been investigated, the behaviour of creatine in the blood and muscle is still not fully understood. Creatine is most probably actively absorbed from the gastrointestinal tract in a similar way to amino acids and peptides. The distribution of creatine throughout the body is largely determined by the presence of creatine transporters. These transporters not only serve to distribute creatine but serve as a clearance mechanism because of creatine ‘trapping’ by skeletal muscle. Besides the pseudo-irreversible uptake by skeletal muscle, creatine clearance also depends on renal elimination and degradation to creatinine.Evidence suggests that creatine pharmacokinetics are nonlinear with respect to dose size and frequency. Skeletal muscle, the largest depot of creatine, has a finite capacity to store creatine. As such, when these stores are saturated, both volume of distribution and clearance can decrease, thus leading to complex pharmacokinetic situations. Additionally, other dietary components such as caffeine and carbohydrate can potentially affect pharmacokinetics by their influence on the creatine transporter. Disease and age may also affect the pharmacokinetics, but more information is needed.Overall, there are very limited pharmacokinetic data available for creatine, and further studies are needed to define absorption characteristics, clearance kinetics and the effect of multiple doses. Additionally, the relationship between plasma creatine and muscle creatine needs to be elucidated to optimise administration regimens. More... »

PAGES

557-574

Identifiers

URI

http://scigraph.springernature.com/pub.10.2165/00003088-200342060-00005

DOI

http://dx.doi.org/10.2165/00003088-200342060-00005

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1020881996

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/12793840


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Pharmacology and Pharmaceutical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Absorption", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Administration, Oral", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Caffeine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Creatine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dietary Carbohydrates", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dietary Supplements", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Interactions", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kidney", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Membrane Transport Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Metabolic Clearance Rate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Muscle, Skeletal", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, Florida, USA", 
          "id": "http://www.grid.ac/institutes/grid.15276.37", 
          "name": [
            "Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, Florida, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Persky", 
        "givenName": "Adam M.", 
        "id": "sg:person.01135500744.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01135500744.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pharmacy Practice and Pharmaceutics, State University of New York at Buffalo, Amherst, New York, USA", 
          "id": "http://www.grid.ac/institutes/grid.273335.3", 
          "name": [
            "Department of Pharmacy Practice and Pharmaceutics, State University of New York at Buffalo, Amherst, New York, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Brazeau", 
        "givenName": "Gayle A.", 
        "id": "sg:person.0677723417.90", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0677723417.90"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, Florida, USA", 
          "id": "http://www.grid.ac/institutes/grid.15276.37", 
          "name": [
            "Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, Florida, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hochhaus", 
        "givenName": "G\u00fcnther", 
        "id": "sg:person.012057046724.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012057046724.28"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1023/a:1011908606819", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039134085", 
          "https://doi.org/10.1023/a:1011908606819"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/6568", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008005540", 
          "https://doi.org/10.1038/6568"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s004210050291", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038282020", 
          "https://doi.org/10.1007/s004210050291"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1203/00006450-199409000-00023", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006902550", 
          "https://doi.org/10.1203/00006450-199409000-00023"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1006895414925", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021072139", 
          "https://doi.org/10.1023/a:1006895414925"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s004210050570", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050465740", 
          "https://doi.org/10.1007/s004210050570"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s004210000370", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035231666", 
          "https://doi.org/10.1007/s004210000370"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00225844", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051443591", 
          "https://doi.org/10.1007/bf00225844"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2003-05", 
    "datePublishedReg": "2003-05-01", 
    "description": "Creatine is a nonessential dietary component that, when supplemented in the diet, has shown physiological benefits in athletes, in animal-based models of disease and in patients with various muscle, neurological and neuromuscular disease. The clinical relevance of creatine supplementation is based primarily on its role in ATP generation, and cells may be able to better handle rapidly changing energy demands with supplementation.Although the pharmacological outcome measures of creatine have been investigated, the behaviour of creatine in the blood and muscle is still not fully understood. Creatine is most probably actively absorbed from the gastrointestinal tract in a similar way to amino acids and peptides. The distribution of creatine throughout the body is largely determined by the presence of creatine transporters. These transporters not only serve to distribute creatine but serve as a clearance mechanism because of creatine \u2018trapping\u2019 by skeletal muscle. Besides the pseudo-irreversible uptake by skeletal muscle, creatine clearance also depends on renal elimination and degradation to creatinine.Evidence suggests that creatine pharmacokinetics are nonlinear with respect to dose size and frequency. Skeletal muscle, the largest depot of creatine, has a finite capacity to store creatine. As such, when these stores are saturated, both volume of distribution and clearance can decrease, thus leading to complex pharmacokinetic situations. Additionally, other dietary components such as caffeine and carbohydrate can potentially affect pharmacokinetics by their influence on the creatine transporter. Disease and age may also affect the pharmacokinetics, but more information is needed.Overall, there are very limited pharmacokinetic data available for creatine, and further studies are needed to define absorption characteristics, clearance kinetics and the effect of multiple doses. Additionally, the relationship between plasma creatine and muscle creatine needs to be elucidated to optimise administration regimens.", 
    "genre": "article", 
    "id": "sg:pub.10.2165/00003088-200342060-00005", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1085321", 
        "issn": [
          "0312-5963", 
          "1179-1926"
        ], 
        "name": "Clinical Pharmacokinetics", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "6", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "42"
      }
    ], 
    "keywords": [
      "skeletal muscle", 
      "dietary components", 
      "creatine transporter", 
      "limited pharmacokinetic data", 
      "volume of distribution", 
      "nonessential dietary components", 
      "distribution of creatine", 
      "creatine clearance", 
      "creatine supplementation", 
      "multiple doses", 
      "renal elimination", 
      "outcome measures", 
      "gastrointestinal tract", 
      "plasma creatine", 
      "pharmacokinetic data", 
      "clinical relevance", 
      "neuromuscular disease", 
      "muscle creatine", 
      "clearance mechanisms", 
      "pharmacokinetics", 
      "clearance kinetics", 
      "animal-based models", 
      "creatine", 
      "muscle", 
      "disease", 
      "Further studies", 
      "physiological benefits", 
      "supplementation", 
      "clearance", 
      "large depots", 
      "ATP generation", 
      "transporters", 
      "patients", 
      "creatinine", 
      "doses", 
      "administration", 
      "blood", 
      "tract", 
      "diet", 
      "age", 
      "amino acids", 
      "athletes", 
      "caffeine", 
      "cells", 
      "more information", 
      "depots", 
      "peptides", 
      "uptake", 
      "evidence", 
      "elimination", 
      "study", 
      "role", 
      "benefits", 
      "measures", 
      "carbohydrates", 
      "relevance", 
      "stores", 
      "effect", 
      "volume", 
      "presence", 
      "acid", 
      "body", 
      "mechanism", 
      "similar way", 
      "frequency", 
      "data", 
      "components", 
      "relationship", 
      "capacity", 
      "characteristics", 
      "information", 
      "distribution", 
      "size", 
      "influence", 
      "situation", 
      "model", 
      "respect", 
      "generation", 
      "kinetics", 
      "absorption characteristics", 
      "behavior", 
      "degradation", 
      "way", 
      "demand", 
      "trapping", 
      "energy demand", 
      "finite capacity"
    ], 
    "name": "Pharmacokinetics of the Dietary Supplement Creatine", 
    "pagination": "557-574", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1020881996"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.2165/00003088-200342060-00005"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "12793840"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.2165/00003088-200342060-00005", 
      "https://app.dimensions.ai/details/publication/pub.1020881996"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-06-01T22:04", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220601/entities/gbq_results/article/article_378.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.2165/00003088-200342060-00005"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.2165/00003088-200342060-00005'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.2165/00003088-200342060-00005'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.2165/00003088-200342060-00005'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.2165/00003088-200342060-00005'


 

This table displays all metadata directly associated to this object as RDF triples.

258 TRIPLES      22 PREDICATES      137 URIs      121 LITERALS      22 BLANK NODES

Subject Predicate Object
1 sg:pub.10.2165/00003088-200342060-00005 schema:about N0afddd18ec594bd0b5ab6827a5f4bc56
2 N0de6f3c4a20e4dcc8a6ae2d4e1d34063
3 N20888582e2c24a9b96a9d77ace4ee69a
4 N2b5cf75e27cf4ceba1690809272b9972
5 N3452c07ab95c48f1a665aa5ba2e749c3
6 N4516a622c1444369b8b73523bdb062b5
7 N8fb9855b36aa45929be5ac8a3e262eb9
8 N99ef8c731366467f875bdcebdcc38e57
9 N9a77fb94795140ccb8bbd84dafd9fec8
10 N9fd996bbe5d446709d872311cda56717
11 Na36213ea78b749678e26fae99bbfffe8
12 Nb966c5dfca5e477388ebc043d9377219
13 Nba113bb88e67459489ef174aa6546986
14 Ndac741754abc48aabc437482334676cc
15 Ne2c0d46be76e4eb6925db8dab8b8fe25
16 anzsrc-for:11
17 anzsrc-for:1115
18 schema:author Ne8dd82dddc5f401e8dedfe2a1aa5677f
19 schema:citation sg:pub.10.1007/bf00225844
20 sg:pub.10.1007/s004210000370
21 sg:pub.10.1007/s004210050291
22 sg:pub.10.1007/s004210050570
23 sg:pub.10.1023/a:1006895414925
24 sg:pub.10.1023/a:1011908606819
25 sg:pub.10.1038/6568
26 sg:pub.10.1203/00006450-199409000-00023
27 schema:datePublished 2003-05
28 schema:datePublishedReg 2003-05-01
29 schema:description Creatine is a nonessential dietary component that, when supplemented in the diet, has shown physiological benefits in athletes, in animal-based models of disease and in patients with various muscle, neurological and neuromuscular disease. The clinical relevance of creatine supplementation is based primarily on its role in ATP generation, and cells may be able to better handle rapidly changing energy demands with supplementation.Although the pharmacological outcome measures of creatine have been investigated, the behaviour of creatine in the blood and muscle is still not fully understood. Creatine is most probably actively absorbed from the gastrointestinal tract in a similar way to amino acids and peptides. The distribution of creatine throughout the body is largely determined by the presence of creatine transporters. These transporters not only serve to distribute creatine but serve as a clearance mechanism because of creatine ‘trapping’ by skeletal muscle. Besides the pseudo-irreversible uptake by skeletal muscle, creatine clearance also depends on renal elimination and degradation to creatinine.Evidence suggests that creatine pharmacokinetics are nonlinear with respect to dose size and frequency. Skeletal muscle, the largest depot of creatine, has a finite capacity to store creatine. As such, when these stores are saturated, both volume of distribution and clearance can decrease, thus leading to complex pharmacokinetic situations. Additionally, other dietary components such as caffeine and carbohydrate can potentially affect pharmacokinetics by their influence on the creatine transporter. Disease and age may also affect the pharmacokinetics, but more information is needed.Overall, there are very limited pharmacokinetic data available for creatine, and further studies are needed to define absorption characteristics, clearance kinetics and the effect of multiple doses. Additionally, the relationship between plasma creatine and muscle creatine needs to be elucidated to optimise administration regimens.
30 schema:genre article
31 schema:inLanguage en
32 schema:isAccessibleForFree false
33 schema:isPartOf N2b1244bbf4a748d39fc5e642213b309c
34 N4d4200726db24fdfb02b3ecc4e434832
35 sg:journal.1085321
36 schema:keywords ATP generation
37 Further studies
38 absorption characteristics
39 acid
40 administration
41 age
42 amino acids
43 animal-based models
44 athletes
45 behavior
46 benefits
47 blood
48 body
49 caffeine
50 capacity
51 carbohydrates
52 cells
53 characteristics
54 clearance
55 clearance kinetics
56 clearance mechanisms
57 clinical relevance
58 components
59 creatine
60 creatine clearance
61 creatine supplementation
62 creatine transporter
63 creatinine
64 data
65 degradation
66 demand
67 depots
68 diet
69 dietary components
70 disease
71 distribution
72 distribution of creatine
73 doses
74 effect
75 elimination
76 energy demand
77 evidence
78 finite capacity
79 frequency
80 gastrointestinal tract
81 generation
82 influence
83 information
84 kinetics
85 large depots
86 limited pharmacokinetic data
87 measures
88 mechanism
89 model
90 more information
91 multiple doses
92 muscle
93 muscle creatine
94 neuromuscular disease
95 nonessential dietary components
96 outcome measures
97 patients
98 peptides
99 pharmacokinetic data
100 pharmacokinetics
101 physiological benefits
102 plasma creatine
103 presence
104 relationship
105 relevance
106 renal elimination
107 respect
108 role
109 similar way
110 situation
111 size
112 skeletal muscle
113 stores
114 study
115 supplementation
116 tract
117 transporters
118 trapping
119 uptake
120 volume
121 volume of distribution
122 way
123 schema:name Pharmacokinetics of the Dietary Supplement Creatine
124 schema:pagination 557-574
125 schema:productId N0a790045e3294419857854182cb32a59
126 N801f25a0c8a84e339f7ee14233c9eeae
127 Nfb50ee9f7ebc402580d675c0eb3b576d
128 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020881996
129 https://doi.org/10.2165/00003088-200342060-00005
130 schema:sdDatePublished 2022-06-01T22:04
131 schema:sdLicense https://scigraph.springernature.com/explorer/license/
132 schema:sdPublisher Nd2a6fe18b43b4f0ab15c5a9501e30119
133 schema:url https://doi.org/10.2165/00003088-200342060-00005
134 sgo:license sg:explorer/license/
135 sgo:sdDataset articles
136 rdf:type schema:ScholarlyArticle
137 N0a790045e3294419857854182cb32a59 schema:name doi
138 schema:value 10.2165/00003088-200342060-00005
139 rdf:type schema:PropertyValue
140 N0afddd18ec594bd0b5ab6827a5f4bc56 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Female
142 rdf:type schema:DefinedTerm
143 N0de6f3c4a20e4dcc8a6ae2d4e1d34063 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Creatine
145 rdf:type schema:DefinedTerm
146 N20888582e2c24a9b96a9d77ace4ee69a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Male
148 rdf:type schema:DefinedTerm
149 N2b1244bbf4a748d39fc5e642213b309c schema:volumeNumber 42
150 rdf:type schema:PublicationVolume
151 N2b5cf75e27cf4ceba1690809272b9972 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Dietary Supplements
153 rdf:type schema:DefinedTerm
154 N3452c07ab95c48f1a665aa5ba2e749c3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Metabolic Clearance Rate
156 rdf:type schema:DefinedTerm
157 N39886445d04a47bb8b3486966b7bb7ef rdf:first sg:person.0677723417.90
158 rdf:rest N4ce2e3a94b894892824db046b0873470
159 N4516a622c1444369b8b73523bdb062b5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Animals
161 rdf:type schema:DefinedTerm
162 N4ce2e3a94b894892824db046b0873470 rdf:first sg:person.012057046724.28
163 rdf:rest rdf:nil
164 N4d4200726db24fdfb02b3ecc4e434832 schema:issueNumber 6
165 rdf:type schema:PublicationIssue
166 N801f25a0c8a84e339f7ee14233c9eeae schema:name pubmed_id
167 schema:value 12793840
168 rdf:type schema:PropertyValue
169 N8fb9855b36aa45929be5ac8a3e262eb9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Humans
171 rdf:type schema:DefinedTerm
172 N99ef8c731366467f875bdcebdcc38e57 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Kidney
174 rdf:type schema:DefinedTerm
175 N9a77fb94795140ccb8bbd84dafd9fec8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Absorption
177 rdf:type schema:DefinedTerm
178 N9fd996bbe5d446709d872311cda56717 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Dietary Carbohydrates
180 rdf:type schema:DefinedTerm
181 Na36213ea78b749678e26fae99bbfffe8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Membrane Transport Proteins
183 rdf:type schema:DefinedTerm
184 Nb966c5dfca5e477388ebc043d9377219 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
185 schema:name Muscle, Skeletal
186 rdf:type schema:DefinedTerm
187 Nba113bb88e67459489ef174aa6546986 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
188 schema:name Caffeine
189 rdf:type schema:DefinedTerm
190 Nd2a6fe18b43b4f0ab15c5a9501e30119 schema:name Springer Nature - SN SciGraph project
191 rdf:type schema:Organization
192 Ndac741754abc48aabc437482334676cc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
193 schema:name Drug Interactions
194 rdf:type schema:DefinedTerm
195 Ne2c0d46be76e4eb6925db8dab8b8fe25 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
196 schema:name Administration, Oral
197 rdf:type schema:DefinedTerm
198 Ne8dd82dddc5f401e8dedfe2a1aa5677f rdf:first sg:person.01135500744.17
199 rdf:rest N39886445d04a47bb8b3486966b7bb7ef
200 Nfb50ee9f7ebc402580d675c0eb3b576d schema:name dimensions_id
201 schema:value pub.1020881996
202 rdf:type schema:PropertyValue
203 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
204 schema:name Medical and Health Sciences
205 rdf:type schema:DefinedTerm
206 anzsrc-for:1115 schema:inDefinedTermSet anzsrc-for:
207 schema:name Pharmacology and Pharmaceutical Sciences
208 rdf:type schema:DefinedTerm
209 sg:journal.1085321 schema:issn 0312-5963
210 1179-1926
211 schema:name Clinical Pharmacokinetics
212 schema:publisher Springer Nature
213 rdf:type schema:Periodical
214 sg:person.01135500744.17 schema:affiliation grid-institutes:grid.15276.37
215 schema:familyName Persky
216 schema:givenName Adam M.
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01135500744.17
218 rdf:type schema:Person
219 sg:person.012057046724.28 schema:affiliation grid-institutes:grid.15276.37
220 schema:familyName Hochhaus
221 schema:givenName Günther
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012057046724.28
223 rdf:type schema:Person
224 sg:person.0677723417.90 schema:affiliation grid-institutes:grid.273335.3
225 schema:familyName Brazeau
226 schema:givenName Gayle A.
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0677723417.90
228 rdf:type schema:Person
229 sg:pub.10.1007/bf00225844 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051443591
230 https://doi.org/10.1007/bf00225844
231 rdf:type schema:CreativeWork
232 sg:pub.10.1007/s004210000370 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035231666
233 https://doi.org/10.1007/s004210000370
234 rdf:type schema:CreativeWork
235 sg:pub.10.1007/s004210050291 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038282020
236 https://doi.org/10.1007/s004210050291
237 rdf:type schema:CreativeWork
238 sg:pub.10.1007/s004210050570 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050465740
239 https://doi.org/10.1007/s004210050570
240 rdf:type schema:CreativeWork
241 sg:pub.10.1023/a:1006895414925 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021072139
242 https://doi.org/10.1023/a:1006895414925
243 rdf:type schema:CreativeWork
244 sg:pub.10.1023/a:1011908606819 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039134085
245 https://doi.org/10.1023/a:1011908606819
246 rdf:type schema:CreativeWork
247 sg:pub.10.1038/6568 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008005540
248 https://doi.org/10.1038/6568
249 rdf:type schema:CreativeWork
250 sg:pub.10.1203/00006450-199409000-00023 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006902550
251 https://doi.org/10.1203/00006450-199409000-00023
252 rdf:type schema:CreativeWork
253 grid-institutes:grid.15276.37 schema:alternateName Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, Florida, USA
254 schema:name Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, Florida, USA
255 rdf:type schema:Organization
256 grid-institutes:grid.273335.3 schema:alternateName Department of Pharmacy Practice and Pharmaceutics, State University of New York at Buffalo, Amherst, New York, USA
257 schema:name Department of Pharmacy Practice and Pharmaceutics, State University of New York at Buffalo, Amherst, New York, USA
258 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...